The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Open accessAbstract
Objective: We aimed to provide an evidence-supported update of the ECCO-ESPGHAN guideline on the medical management of paediatric Crohn’s disease [CD]. Methods: We formed 10 working groups and formulated 17 PICO-structured clinical questions [Patients, Intervention, Comparator, and Outcome]. A systematic literature search from January 1, 1991 to March 19, 2019 was conducted by a medical librarian using MEDLINE, EMBASE, and Cochrane Central databases. A shortlist of 30 provisional statements were further refined during a consensus meeting in Barcelona in October 2019 and subjected to a vote. In total 22 statements reached ≥ 80% agreement and were retained. Results: We established that it was key to identify patients at high risk of a complicated disease course at the earliest opportunity, to reduce bowel damage. Patients with perianal disease, stricturing or penetrating behaviour, or severe growth retardation should be considered for up-front anti-tumour necrosis factor [TNF] agents in combination with an immunomodulator. Therapeutic drug monitoring to guide treatment changes is recommended over empirically escalating anti-TNF dose or switching therapies. Patients with low-risk luminal CD should be induced with exclusive enteral nutrition [EEN], or with corticosteroids when EEN is not an option, and require immunomodulator-based maintenance therapy. Favourable outcomes rely on close monitoring of treatment response, with timely adjustments in therapy when treatment targets are not met. Serial faecal calprotectin measurements or small bowel imaging [ultrasound or magnetic resonance enterography] are more reliable markers of treatment response than clinical scores alone. Conclusions: We present state-of-the-art guidance on the medical treatment and long-term management of children and adolescents with CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Self-citationPredictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Levine, A., Koletzko, S., Turner, D., Escher, J. C., Cucchiara, S., de Ridder, L., Kolho, K., Veres, G., Russell, R. K., Paerregaard, A., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000239 · Cited by 1,394
Self-citationUstekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Beaugerie, L., Brousse, N., Bouvier, A. M., Colombel, J. F., Lémann, M., Cosnes, J., Hébuterne, X., Cortot, A., Bouhnik, Y., Gendre, J. P., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61302-7 · Cited by 1,115
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease
Ruemmele, F. M., Veres, G., Kolho, K. L., Griffiths, A., Levine, A., Escher, J. C., Amil Dias, J., Barabino, A., Braegger, C. P., Bronsky, J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.005 · Cited by 1,083
Rahier, J. F., Magro, F., Abreu, C., Armuzzi, A., Ben-Horin, S., Chowers, Y., Cottone, M., de Ridder, L., G., D., Ehehalt, R., et al. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.12.013 · Cited by 923
Self-citationColombel, J.-F., Panaccione, R., Bossuyt, P., Lukas, M., Baert, F., Vaňásek, T., Danalioglu, A., Novacek, G., Armuzzi, A., Hébuterne, X., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32641-7 · Cited by 921
Hyams, J., Crandall, W., Kugathasan, S., Griffiths, A., Olson, A., Johanns, J., Liu, G., Travers, S., Heuschkel, R., Markowitz, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.003 · Cited by 877
Self-citationThe safety of vedolizumab for ulcerative colitis and Crohn's disease
Colombel, J.-F., Sands, B. E., Rutgeerts, P., Sandborn, W., Danese, S., D'Haens, G., Panaccione, R., Loftus, E. V., Sankoh, S., Fox, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311079 · Cited by 806
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Markowitz, J., Grancher, K., Kohn, N., Lesser, M., & Daum, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.18144 · Cited by 716
Sands, B. E., Feagan, B. G., Rutgeerts, P., Colombel, J.-F., Sandborn, W. J., Sy, R., D’Haens, G., Ben-Horin, S., Xu, J., Rosario, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.008 · Cited by 715
Kennedy, N. A., Heap, G. A., Green, H. D., Hamilton, B., Bewshea, C., Walker, G. J., Thomas, A., Nice, R., Perry, M. H., Bouri, S., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30012-3 · Cited by 691
Self-citationLevine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., Cohen, S., Peleg, S., Shamaly, H., On, A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.021 · Cited by 671
Self-citationKugathasan, S., Denson, L. A., Walters, T. D., Kim, M.-O., Marigorta, U. M., Schirmer, M., Mondal, K., Liu, C., Griffiths, A., Noe, J. D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30317-3 · Cited by 633
Self-citationCrohn's disease management after intestinal resection: a randomised trial
De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 619
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Regueiro, M., Schraut, W., Baidoo, L., Kip, K. E., Sepulveda, A. R., Pesci, M., Harrison, J., & Plevy, S. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.051 · Cited by 601
Enteral nutritional therapy for induction of remission in Crohn's disease
Zachos, M., Tondeur, M., & Griffiths, A. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub2 · Cited by 598
Self-citationLemaitre, M., Kirchgesner, J., Rudnichi, A., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2017) · JAMA · doi:10.1001/jama.2017.16071 · Cited by 575
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Yang, S.-K., Hong, M., Baek, J., Choi, H., Zhao, W., Jung, Y., Haritunians, T., Ye, B. D., Kim, K.-J., Park, S. H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3060 · Cited by 549
ASPEN Consensus Recommendations for Refeeding Syndrome
da Silva, J. S. V., Seres, D. S., Sabino, K., Adams, S. C., Berdahl, G. J., Citty, S. W., Cober, M. P., Evans, D. C., Greaves, J. R., Gura, K. M., et al. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10474 · Cited by 542
Peyrin-Biroulet, L., Reinisch, W., Colombel, J.-F., Mantzaris, G. J., Kornbluth, A., Diamond, R., Rutgeerts, P., Tang, L. K., Cornillie, F. J., & Sandborn, W. J. (2014) · Gut · doi:10.1136/gutjnl-2013-304984 · Cited by 502
Van Assche, G., Magdelaine–Beuzelin, C., D'Haens, G., Baert, F., Noman, M., Vermeire, S., Ternant, D., Watier, H., Paintaud, G., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.004 · Cited by 495
Kotlyar, D. S., Osterman, M. T., Diamond, R. H., Porter, D., Blonski, W. C., Wasik, M., Sampat, S., Mendizabal, M., Lin, M. V., & Lichtenstein, G. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.016 · Cited by 477
Borrelli, O., Cordischi, L., Cirulli, M., Paganelli, M., Labalestra, V., Uccini, S., Russo, P. M., & Cucchiara, S. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.010 · Cited by 471
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Annese, V., Beaugerie, L., Egan, L., Biancone, L., Bolling, C., Brandts, C., Dierickx, D., Dummer, R., Fiorino, G., Gornet, J. M., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv141 · Cited by 428
Sazonovs, A., Kennedy, N. A., Moutsianas, L., Heap, G. A., Rice, D. L., Reppell, M., Bewshea, C. M., Chanchlani, N., Walker, G. J., Perry, M. H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.041 · Cited by 423
Self-citationKotlyar, D. S., Lewis, J. D., Beaugerie, L., Tierney, A., Brensinger, C. M., Gisbert, J. P., Loftus, E. V., Peyrin-Biroulet, L., Blonski, W. C., Van Domselaar, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.05.015 · Cited by 414
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Chande, N., Patton, P. H., Tsoulis, D. J., Thomas, B. S., & MacDonald, J. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067.pub3 · Cited by 402
ECCO-ESCP Consensus on Surgery for Crohn’s Disease
Bemelman, W. A., Warusavitarne, J., Sampietro, G. M., Serclova, Z., Zmora, O., Luglio, G., de Buck van Overstraeten, A., Burke, J. P., Buskens, C. J., Francesco, C., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx061 · Cited by 399
Self-citationBousvaros, A., Guandalini, S., Baldassano, R. N., Botelho, C., Evans, J., Ferry, G. D., Goldin, B., Hartigan, L., Kugathasan, S., Levy, J., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000175905.00212.2c · Cited by 363
Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., Plevy, S., Popp, J., Cornillie, F. J., Lukas, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.072 · Cited by 339
Feagan, B. G., McDonald, J. W. D., Panaccione, R., Enns, R. A., Bernstein, C. N., Ponich, T. P., Bourdages, R., MacIntosh, D. G., Dallaire, C., Cohen, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.024 · Cited by 331
Svolos, V., Hansen, R., Nichols, B., Quince, C., Ijaz, U. Z., Papadopoulou, R. T., Edwards, C. A., Watson, D., Alghamdi, A., Brejnrod, A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.002 · Cited by 317
Self-citationGanji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
Hyams, J. S., Griffiths, A., Markowitz, J., Baldassano, R. N., Faubion, W. A., Colletti, R. B., Dubinsky, M., Kierkus, J., Rosh, J., Wang, Y., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.046 · Cited by 311
Self-citationD’Haens, G., Vermeire, S., Lambrecht, G., Baert, F., Bossuyt, P., Pariente, B., Buisson, A., Bouhnik, Y., Filippi, J., vander Woude, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.004 · Cited by 305
Turner, D., Griffiths, A. M., Walters, T. D., Seah, T., Markowitz, J., Pfefferkorn, M., Keljo, D., Waxman, J., Otley, A., LeLeiko, N. S., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21649 · Cited by 301
Self-citationEnteral nutritional therapy for induction of remission in Crohn's disease
Narula, N., Dhillon, A., Zhang, D., Sherlock, M. E., Tondeur, M., & Zachos, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub3 · Cited by 301
Cholapranee, A., Hazlewood, G. S., Kaplan, G. G., Peyrin‐Biroulet, L., & Ananthakrishnan, A. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14030 · Cited by 296
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Bouguen, G., Levesque, B. G., Feagan, B. G., Kavanaugh, A., Peyrin–Biroulet, L., Colombel, J., Hanauer, S. B., & Sandborn, W. J. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.006 · Cited by 294
TAKAGI, S., UTSUNOMIYA, K., KURIYAMA, S., YOKOYAMA, H., TAKAHASHI, S., IWABUCHI, M., TAKAHASHI, H., TAKAHASHI, S., KINOUCHI, Y., HIWATASHI, N., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03120.x · Cited by 292
Walters, T. D., Kim, M.-O., Denson, L. A., Griffiths, A. M., Dubinsky, M., Markowitz, J., Baldassano, R., Crandall, W., Rosh, J., Pfefferkorn, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.027 · Cited by 275
Self-citationSupplementary enteral nutrition maintains remission in paediatric Crohn's disease.
Wilschanski, M., Sherman, P., Pencharz, P., Davis, L., Corey, M., & Griffiths, A. (1996) · Gut · doi:10.1136/gut.38.4.543 · Cited by 262
Self-citationProbiotics for maintenance of remission in Crohn's disease
Rolfe, V. E., Fortun, P. J., Hawkey, C. J., & Bath-Hextall, F. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004826.pub2 · Cited by 251
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Dubinsky, M. C., Kugathasan, S., Mei, L., Picornell, Y., Nebel, J., Wrobel, I., Quiros, A., Silber, G., Wahbeh, G., Katzir, L., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.032 · Cited by 245
Battat, R., Kopylov, U., Bessissow, T., Bitton, A., Cohen, A., Jain, A., Martel, M., Seidman, E., & Afif, W. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.03.032 · Cited by 239
Matsumoto, T., Motoya, S., Watanabe, K., Hisamatsu, T., Nakase, H., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Esaki, M., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw152 · Cited by 238
Sipponen, T., Savilahti, E., Kärkkäinen, P., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20490 · Cited by 236
Self-citationSingh, S., Facciorusso, A., Dulai, P. S., Jairath, V., & Sandborn, W. J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.044 · Cited by 229
Hyams, J. S., Dubinsky, M. C., Baldassano, R. N., Colletti, R. B., Cucchiara, S., Escher, J., Faubion, W., Fell, J., Gold, B. D., Griffiths, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.004 · Cited by 218
Self-citationDervieux, T., & Boulieu, R. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.3.551 · Cited by 215
Long-term Efficacy of Vedolizumab for Crohn’s Disease
Vermeire, S., Loftus, E. V., Colombel, J.-F., Feagan, B. G., Sandborn, W. J., Sands, B. E., Danese, S., D’Haens, G. R., Kaser, A., Panaccione, R., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw176 · Cited by 215
Probiotics for induction of remission in Crohn's disease
Limketkai, B. N., Akobeng, A. K., Gordon, M., & Adepoju, A. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006634.pub3 · Cited by 203
Coenen, M. J. H., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J. J., Vermeulen, S. H., Wong, D. R., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Peters, W. H. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.002 · Cited by 199
Roblin, X., Rinaudo, M., Del Tedesco, E., Phelip, J. M., Genin, C., Peyrin-Biroulet, L., & Paul, S. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.146 · Cited by 195
Baumgart, D. C., Bokemeyer, B., Drabik, A., Stallmach, A., Schreiber, S., & the Vedolizumab Germany Consortium (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13594 · Cited by 189
Colombel, J.-F., Adedokun, O. J., Gasink, C., Gao, L.-L., Cornillie, F. J., D'Haens, G. R., Rutgeerts, P. J., Reinisch, W., Sandborn, W. J., & Hanauer, S. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.033 · Cited by 189
Sands, B. E., Sandborn, W. J., Van Assche, G., Lukas, M., Xu, J., James, A., Abhyankar, B., & Lasch, K. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000979 · Cited by 186
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort
Shelton, E., Allegretti, J. R., Stevens, B., Lucci, M., Khalili, H., Nguyen, D. D., Sauk, J., Giallourakis, C., Garber, J., Hamilton, M. J., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000561 · Cited by 185
Calabrese, E., Maaser, C., Zorzi, F., Kannengiesser, K., Hanauer, S. B., Bruining, D. H., Iacucci, M., Maconi, G., Novak, K. L., Panaccione, R., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000706 · Cited by 183
Methotrexate for maintenance of remission in Crohn's disease
Patel, V., Wang, Y., MacDonald, J. K., McDonald, J. W., & Chande, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006884.pub3 · Cited by 180
Ferrante, M., Colombel, J., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G. R., van der Woude, C. J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.010 · Cited by 179
Schreiber, S., Dignass, A., Peyrin-Biroulet, L., Hather, G., Demuth, D., Mosli, M., Curtis, R., Khalid, J. M., & Loftus, E. V. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1480-0 · Cited by 175
Swaminath, A., Feathers, A., Ananthakrishnan, A. N., Falzon, L., & Li Ferry, S. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14253 · Cited by 174
Walker, G. J., Harrison, J. W., Heap, G. A., Voskuil, M. D., Andersen, V., Anderson, C. A., Ananthakrishnan, A. N., Barrett, J. C., Beaugerie, L., Bewshea, C. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.0709 · Cited by 171
Self-citationGhione, S., Sarter, H., Fumery, M., Armengol-Debeir, L., Savoye, G., Ley, D., Spyckerelle, C., Pariente, B., Peyrin-Biroulet, L., Turck, D., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.228 · Cited by 168
Rubio, A., Pigneur, B., Garnier-Lengliné, H., Talbotec, C., Schmitz, J., Canioni, D., Goulet, O., & Ruemmele, F. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04662.x · Cited by 165
Self-citationFecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub2 · Cited by 164
Yamamoto, T., Nakahigashi, M., Umegae, S., Kitagawa, T., & Matsumoto, K. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03158.x · Cited by 162
Yarur, A. J., Kubiliun, M. J., Czul, F., Sussman, D. A., Quintero, M. A., Jain, A., Drake, K. A., Hauenstein, S. I., Lockton, S., Deshpande, A. R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.12.026 · Cited by 161
Pigneur, B., Lepage, P., Mondot, S., Schmitz, J., Goulet, O., Dore, J. M., & Ruemmele, F. M. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy207 · Cited by 161
Self-citationFecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O., Borromeo Beaulieu, D. M., & Acra, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774 · Cited by 158
Heida, A., Park, K. T., & van Rheenen, P. F. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001082 · Cited by 157
Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
Engel, T., Ungar, B., Yung, D. E., Ben‐Horin, S., Eliakim, R., & Kopylov, U. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx143 · Cited by 155
Ardizzone, S., Bollani, S., Manzionna, G., Imbesi, V., Colombo, E. M., & Porro, G. B. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00372-4 · Cited by 150
Cruz, P. P. D., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13353 · Cited by 147
Papamichael, K., Juncadella, A. C., Wong, D., Rakowsky, S. T., Sattler, L., Campbell, J. P., Vaughn, B. P., & Cheifetz, A. S. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz018 · Cited by 143
Yamamoto, T., Nakahigashi, M., Saniabadi, A. R., Iwata, T., Maruyama, Y., Umegae, S., & Matsumoto, K. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20238 · Cited by 140
Fang, H., Fu, L., & Wang, J. (2018) · BioMed Research International · doi:10.1155/2018/8941340 · Cited by 139
Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-analysis
Lee, M. J., Parker, C. E., Taylor, S. R., Guizzetti, L., Feagan, B. G., Lobo, A., & Jairath, V. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.030 · Cited by 138
Roblin, X., Boschetti, G., Williet, N., Nancey, S., Marotte, H., Berger, A., Phelip, J., Peyrin‐Biroulet, L., Colombel, J., Tedesco, É. D., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14106 · Cited by 135
Weinstein-Nakar, I., Focht, G., Church, P. C., Walters, T. D., Abitbol, G., Anupindi, S. A., Berteloot, L., Hulst, J. M., Ruemmele, F. M., Lemberg, D. A., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.024 · Cited by 135
Self-citationOliva, S., Thomson, M. A., de Ridder, L., de Carpi, J. M., Biervliet, S. V., Braegger, C., Dias, J. A., Kolaček, S., Miele, E., Buderus, S., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002092 · Cited by 128
Self-citationAmre, D. K., Lu, S., Costea, F., & Seidman, E. G. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00468.x · Cited by 126
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
Turner, D., Levine, A., Walters, T. D., Focht, G., Otley, A. R., López, V. N., Koletzko, S., Baldassano, R. N., Mack, D. R., Hyams, J. S., et al. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001227 · Cited by 126
Self-citationde Groof, E. J., Sahami, S., Lucas, C., Ponsioen, C. Y., Bemelman, W. A., & Buskens, C. J. (2016) · Colorectal Disease · doi:10.1111/codi.13311 · Cited by 125
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Singh, N., Rabizadeh, S., Jossen, J., Pittman, N. S., Check, M. S., Hashemi, G., Phan, B. L., Hyams, J. S., & Dubinsky, M. C. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000865 · Cited by 125
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Chande, N., Townsend, C., Parker, C. E., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub5 · Cited by 122
Jones, J., Kaplan, G. G., Peyrin‐Biroulet, L., Baidoo, L., Devlin, S. M., Melmed, G., Tanyingoh, D., Raffals, L. E., Irving, P. M., Kozuch, P. L., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.034 · Cited by 120
Kopylov, U., Yung, D. E., Engel, T., Avni, T., Battat, R. J., Ben‐Horin, S., Plevris, J. N., Eliakim, R., & Koulaouzidis, A. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000692 · Cited by 119
Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease
Turner, D., Grossman, A. B., Rosh, J. R., Kugathasan, S., Gilman, A. R., Baldassano, R. N., & Griffiths, A. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01474.x · Cited by 118
Self-citationEffect of early immunomodulator use in moderate to severe pediatric Crohn disease
Punati, J. B., Markowitz, J. F., Lerer, T., Hyams, J. S., Kugathasan, S., Griffiths, A. M., Otley, A. R., Rosh, J. R., Pfefferkorn, M. D., Mack, D. R., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20412 · Cited by 115
Self-citationTeich, N., Mohl, W., Bokemeyer, B., Bündgens, B., Büning, J., Miehlke, S., Hüppe, D., Maaser, C., Klugmann, T., Kruis, W., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv188 · Cited by 115
Moreno, N., Ripollés, T., Paredes, J. M. R., Ortíz, I., Martínez, M. J., López‐Serrano, A., Delgado, F., & Osset, E. M. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.02.008 · Cited by 113
Age-Dependent Variations in Fecal Calprotectin Concentrations in Children
Rugtveit, J., & Fagerhol, M. K. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200203000-00022 · Cited by 111
Escher, J. C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200401000-00008 · Cited by 109
Self-citationDias, J. A., Kolaček, S., Turner, D., Pærregaard, A., Rintala, R. J., Afzal, N. A., Karolewska‐Bochenek, K., Bronský, J., Chong, S. K. F., Fell, J. M. E., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001562 · Cited by 109
Self-citationHyams, J. S., Walters, T. D., Crandall, W., Kugathasan, S., Griffiths, A. M., BLANK, M. A., Johanns, J., Lang, Y., Markowitz, J. F., Cohen, S. A., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.547575 · Cited by 108
Self-citationRapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases
Feagan, B. G., Lasch, K. L., Lissoos, T. W., Cao, C., Wojtowicz, A. M., Khalid, J. M., & Colombel, J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.026 · Cited by 108
Grover, Z., & Lewindon, P. J. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000388 · Cited by 104
Chaparro, M., Garre, A., Ricart, E., Iborra, M., Mesonero, F., Vera, I., Riestra, S., García-Sánchez, V., Castro, M. L. D., Martín‐Cardona, A., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14930 · Cited by 103
Church, P. C., Guan, J., Walters, T. D., Frost, K., Assa, A., Muise, A. M., & Griffiths, A. M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000083 · Cited by 102
Self-citationLennard, L. (1987) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80340-7 · Cited by 101
Lazzerini, M., Martelossi, S., Magazzù, G., Pellegrino, S., Lucanto, M. C., Barabino, A. V., Calvi, A., Arrigo, S., Lionetti, P., Lorusso, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.280777 · Cited by 101
Grossi, V., Lerer, T., Griffiths, A. M., LeLeiko, N. S., Cabrera, J. M., Otley, A. R., Rick, J., Mack, D. R., Bousvaros, A., Rosh, J. R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.04.010 · Cited by 100
Self-citationProbiotics for induction of remission in Crohn's disease
Butterworth, A. D., Thomas, A. G., & Akobeng, A. K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006634.pub2 · Cited by 100
Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease
MacDonald, J. K., Nguyen, T. M., Khanna, R., & Timmer, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007572.pub3 · Cited by 96
Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
Scribano, M. L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i23.2457 · Cited by 96
Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice
Vivio, E. E., Kanuri, N. D., Gilbertsen, J. J., Monroe, K. M., Dey, N., Chen, C.-H., Gutierrez, A. M., & Ciorba, M. A. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv226 · Cited by 95
Nguyen, D. L., Palmer, L. B., Nguyen, E. T., McClave, S. A., Martindale, R. G., & Bechtold, M. L. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15578607 · Cited by 94
Methotrexate in patients with Crohn's disease after 6-mercaptopurine
Mack, D. R., Young, R., Kaufman, S. S., Ramey, L., & Vanderhoof, J. A. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70313-0 · Cited by 93
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease
Levine, A., Turner, D., Gik, T. P., Dias, J. A., Veres, G., Shaoul, R. R., Staiano, A., Escher, J. C., Kolho, K., Pærregaard, A., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437735.11953.68 · Cited by 92
Self-citationChurch, P. C., Turner, D., Feldman, B. M., Walters, T. D., Greer, M., Amitai, M., Griffiths, A. M., & the ImageKids Study Group (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13024 · Cited by 91
Self-citationKelly, O., Sarah, O., Stempak, J. M., Steinhart, A. H., & Silverberg, M. S. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001126 · Cited by 91
Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
Conrad, M. A., Stein, R. E., Maxwell, E. C., Albenberg, L. G., Baldassano, R. N., Dawany, N. B., Grossman, A. B., Mamula, P., Piccoli, D. A., & Kelsen, J. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000918 · Cited by 90
Christensen, B., Gibson, P. R., Micić, D., Colman, R. J., Goeppinger, S. R., Kassim, O., Yarur, A. J., Weber, C. R., Cohen, R. D., & Rubin, D. T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.060 · Cited by 90
Fecal calprotectin in healthy children
Oord, T., & Hornung, N. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.879732 · Cited by 89
Shah, E. D., Farida, J. P., Siegel, C. A., Chong, K., & Melmed, G. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001049 · Cited by 89
Fistula Healing in Pivotal Studies of Ustekinumab in Crohn's Disease
Sands, B. E., Gasink, C., Jacobstein, D., Gao, L.-L., Johanns, J., Colombel, J., de Villiers, W. J. S., & Sandborn, W. J. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)30930-7 · Cited by 88
Cohen-Dolev, N., Sładek, M., Hussey, S., Turner, D., Veres, G., Koletzko, S., de Carpi, J. M., Staiano, A., Shaoul, R. R., Lionetti, P., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx150 · Cited by 88
Self-citationRetrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Meserve, J. D., Aniwan, S., Koliani‐Pace, J. L., Shashi, P., Weiss, A., Faleck, D. M., Winters, A. C., Chablaney, S., Kochhar, G. S., Boland, B. S., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.035 · Cited by 86
Martelli, L., Olivera, P. A., Roblin, X., Attar, A., & Peyrin‐Biroulet, L. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1266-1 · Cited by 84
Efficacy of methotrexate in pediatric Crohnʼs disease: A French multicenter study
Uhlen, S., Belbouab, R., Narebski, K., Goulet, O., Schmitz, J., Cézard, J., Turck, D., & Ruemmele, F. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235103.47280.bb · Cited by 83
Self-citationYung, D. E., Har‐Noy, O., Tham, Y. S., Ben‐Horin, S., Eliakim, R., Koulaouzidis, A., & Kopylov, U. (2017) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx027 · Cited by 83
Cozijnsen, M. A., Shoham, A. B., Kang, B., Choe, B., Choe, Y. H., Jongsma, M., Russell, R. K., Ruemmele, F. M., Escher, J. C., de Ridder, L., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.012 · Cited by 83
Self-citationLogan, M., Clark, C., Ijaz, U. Z., Gervais, L., Duncan, H., Garrick, V., Curtis, L., Buchanan, E., Cardigan, T., Armstrong, L., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15425 · Cited by 83
Self-citationLuthra, P., Peyrin‐Biroulet, L., & Ford, A. C. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13215 · Cited by 82
Antibiotics for induction and maintenance of remission in Crohn's disease
Townsend, C., Parker, C. E., MacDonald, J. K., Nguyen, T. M., Jairath, V., Feagan, B. G., & Khanna, R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012730.pub2 · Cited by 81
Noman, M., Ferrante, M., Bisschops, R., Hertogh, G. D., den Broeck, K. V., Rans, K., Rutgeerts, P., Vermeire, S., & Assche, G. V. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx048 · Cited by 78
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Shmidt, E., Kochhar, G. S., Hartke, J. G., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy171 · Cited by 78
Newman, W. G., Payne, K., Tricker, K. J., Roberts, S. A., Fargher, E., Pushpakom, S. P., Alder, J. E., Sidgwick, G. P., Payne, D., Elliott, R. A., et al. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.32 · Cited by 75
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease
Hanai, H., Iida, T., Takeuchi, K., Arai, H., Arai, O., Abe, J., Tanaka, T., Maruyama, Y., Ikeya, K., Sugimoto, K., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.03.007 · Cited by 74
Kopylov, U., Verstockt, B., Biedermann, L., Sebastian, S., Pugliese, D., Sonnenberg, E., Steinhagen, P., Arebi, N., Ron, Y., Kucharzik, T. F., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy155 · Cited by 74
Mack, D. R., Benchimol, E. I., Critch, J., deBruyn, J. C. C., Tse, F., Moayyedi, P., Church, P. C., Deslandres, C., El‐Matary, W., Huynh, H. Q., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.022 · Cited by 74
Self-citationKang, B., Choi, S. Y., Kim, H. S., Kim, K., Lee, Y. M., & Choe, Y. H. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw086 · Cited by 72
Tham, Y. S., Yung, D. E., Fay, S., Yamamoto, T., Ben‐Horin, S., Eliakim, R., Koulaouzidis, A., & Kopylov, U. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818785571 · Cited by 72
Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH
Crandall, W., Hyams, J. S., Kugathasan, S., Griffiths, A. M., Zrubek, J., Olson, A. D., Liu, G., Heuschkel, R. B., Markowitz, J. F., Cohen, S. A., et al. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181a70f21 · Cited by 68
Self-citationAgrawal, A., Durrani, S., Leiper, K., Ellis, A., Morris, A. I., & Rhodes, J. M. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00759-7 · Cited by 68
Costello, R. E., Patel, R., HUMPHREYS, J. H., McBeth, J., & Dixon, W. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014603 · Cited by 68
Duncan, H., Buchanan, E., Cardigan, T., Garrick, V., Curtis, L., McGrogan, P., Barclay, A., & Russell, R. K. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-50 · Cited by 66
Self-citationFolate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis
Liu, L., Liu, S., Wang, C., Guan, W., Zhang, Y., Hu, W., Zhang, L., He, Y., Lu, J., Li, T., et al. (2018) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000810 · Cited by 66
Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease
Yang, C., Singh, P., Singh, H., Lê, M., & El‐Matary, W. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13181 · Cited by 61
Lenti, M. V., Levison, S., Eliadou, E., Willert, R. P., Kemp, K., Carter, A., Stansfield, C. J., Assadsangabi, A., Singh, S., Crooks, B. J., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.07.007 · Cited by 61
Biancone, L., Annese, V., Ardizzone, S., Armuzzi, A., Calabrese, E., Caprioli, F., Castiglione, F., Comberlato, M., Cottone, M., Danese, S., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.141 · Cited by 60
Sayani, F. A., Prosser, C., Bailey, R. J., Jacobs, P., & Fedorak, R. N. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/470863 · Cited by 59
Tolerance and efficacy of azathioprine in pediatric Crohnʼs disease
Riello, L., Talbotec, C., Garnier‐Lengliné, H., Pigneur, B., Svahn, J. C. E., Canioni, D., Goulet, O., Schmitz, J., & Ruemmele, F. M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21612 · Cited by 59
Self-citationKierkuś, J., Iwańczak, B. M., Wegner, A., Dądalski, M., Grzybowska‐Chlebowczyk, U., Łazowska‐Przeorek, I., Maślana, J., Toporowska‐Kowalska, E., Czaja‐Bulsa, G., Mierzwa, G., et al. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000684 · Cited by 58
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
Hämäläinen, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i47.5166 · Cited by 55
Lee, Y. M., Kang, B., Lee, Y. M., Kim, M. J., & Choe, Y. H. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000711 · Cited by 55
Joosse, M. E., Aardoom, M. A., Kemos, P., Turner, D., Wilson, D. C., Koletzko, S., Martin‐de‐Carpi, J., Fagerberg, U. L., Spray, C., Tzivinikos, C., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14893 · Cited by 54
Self-citationWillot, S., Noble, A. J., & Deslandres, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21653 · Cited by 54
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres
Samaan, M., Pavlidis, P., Johnston, E., Warner, B. D., Digby-Bell, J. L., Koumoutsos, I., Fong, S. C. M., Goldberg, R., Patel, K., Gulati, S., et al. (2016) · Frontline Gastroenterology · doi:10.1136/flgastro-2016-100720 · Cited by 51
Christensen, B., Colman, R. J., Micić, D., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx067 · Cited by 51
de Francisco, R., Castaño‐García, A., González, S. M., Pérez‐Martínez, I., González‐Huerta, A. J., Morais, L. R., Fernández‐García, M. S., Jiménez, S., Coto, S. D., Flórez-Díez, P., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14933 · Cited by 50
Methotrexate in patients with Crohn's diease after 6-mercaptopurine
Mack (1998) · Jornal de Pediatria · Cited by 50
Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease
Valentino, P. L., Church, P. C., Shah, P. S., Beyene, J., Griffiths, A. M., Feldman, B. M., & Kamath, B. M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436953.88522.3e · Cited by 49
Self-citationSvolos, V., Gerasimidis, K., Buchanan, E., Curtis, L., Garrick, V., Hay, J., Laird, S., Munro, J. I., Gaya, D. R., Russell, R. K., et al. (2017) · BMC Gastroenterology · doi:10.1186/s12876-016-0564-7 · Cited by 48
Self-citationYoon, H. M., Suh, C. H., Kim, J. R., Lee, J. S., Jung, A. Y., Kim, K. M., & Cho, Y. A. (2017) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.3400 · Cited by 48
Weiß, B., Lerner, A., Shapiro, R., Broide, E., Levine, A., Fradkin, A., & Bujanover, Y. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318196df3e · Cited by 46
Self-citationLevine, A., Kori, M., Kierkus, J., Boneh, R. S., Sładek, M., Escher, J. C., Wine, E., Yerushalmi, B., Dias, J. A., Shaoul, R. R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315199 · Cited by 46
Self-citationRetrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohnʼs Disease
Sunseri, W. M., Hyams, J. S., Lerer, T., Mack, D. R., Griffiths, A. M., Otley, A. R., Rosh, J. R., Carvalho, R. S., Grossman, A. B., Cabrera, J. M., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000102 · Cited by 44
Self-citationEfficacy of oral methotrexate in paediatric Crohn’s disease: a multicentre propensity score study
Turner, D., Doveh, E., Cohen, A., Wilson, M. L., Grossman, A. B., Rosh, J. R., Lu, Y., Bousvaros, A., Deslandres, C., Noble, A. J., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307964 · Cited by 44
Self-citationMartinelli, M., Giugliano, F. P., Strisciuglio, C., Urbonas, V., Serban, D. E., Banaszkiewicz, A., Assa, A., Hojsak, I., Lerchová, T., Navas‐López, V. M., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz264 · Cited by 44
Self-citationAzathioprine Maintains first remission in newly diagnosed pediatric Crohnʼs disease
Jaspers, G. J., Verkade, H. J., Escher, J. C., de Ridder, L., Taminiau, J. A. J. M., & Rings, E. H. H. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000232470.00703.67 · Cited by 43
Self-citationvan Rheenen, P. F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22896 · Cited by 43
Friedman, A. B., Brown, S. J., Bampton, P. A., Barclay, M. L., Chung, A., Macrae, F., McKenzie, J. E., Reynolds, J., Gibson, P. R., Hanauer, S. B., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14571 · Cited by 43
Kuenzig, M. E., Rezaie, A. R., Kaplan, G. G., Otley, A. R., Steinhart, A. H., Griffiths, A. M., Benchimol, E. I., & Seow, C. H. (2018) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy018 · Cited by 43
Self-citationRestellini, S., Chao, C., Lakatos, P. L., Aruljothy, A., Aziz, H., Kherad, O., Bitton, A., Wild, G., Afif, W., & Bessissow, T. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy044 · Cited by 40
Methotrexate for the Treatment of Pediatric Crohn’s Disease: A Systematic Review and Meta-analysis
Colman, R. J., Lawton, R. C., Dubinsky, M. C., & Rubin, D. T. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy078 · Cited by 40
Role of Methotrexate in the Management of Crohn Disease
Ravikumara, M., Hinsberger, A., & Spray, C. H. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3180320689 · Cited by 39
Nutritional support in paediatric Crohn's disease: outcome at 12 months
Gavin, J., Ashton, J. J., Heather, N., Marino, L. V., & Beattie, R. M. (2017) · Acta Paediatrica · doi:10.1111/apa.14075 · Cited by 38
Papamichael, K., Vajravelu, R. K., Osterman, M. T., & Cheifetz, A. S. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4917-7 · Cited by 38
Antibiotics for induction and maintenance of remission in Crohn's disease
Townsend, C., Parker, C. E., MacDonald, J. K., Jairath, V., Feagan, B. G., & Khanna, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012730 · Cited by 37
Ruemmele, F. M., Rosh, J. R., Faubion, W. A., Dubinsky, M. C., Turner, D., Lazar, A., Eichner, S. F., Maa, J., Alperovich, G., Robinson, A. M., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy087 · Cited by 36
Self-citationCalprotectin instability may lead to undertreatment in children with IBD
Haisma, S., van Rheenen, P. F., Wagenmakers-Huizenga, L. M. F., & Kobold, A. C. M. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316584 · Cited by 36
Kempinska, A., Benchimol, E. I., Mack, A., Barkey, J. L., Boland, M., & Mack, D. R. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31822855e7 · Cited by 35
Merras‐Salmio, L., & Kolho, K. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001258 · Cited by 35
Self-citationSchulman, J. M., Pritzker, L., & Shaoul, R. R. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/5873158 · Cited by 35
Kopylov, U., Avni‐Biron, I., Ron, Y., Koslowsky, B., Waterman, M., Daher, S., Ungar, B., Schwartz, D., Zittan, E., Openhaim, M., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.07.040 · Cited by 35
Levine, A., Kori, M., Dinari, G., Broide, E., Shaoul, R. R., Yerushalmi, B., On, A., Bujanover, Y., Proels, M., & Greinwald, R. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20881 · Cited by 33
Self-citationCozijnsen, M. A., van Pieterson, M., Samsom, J. N., Escher, J. C., & de Ridder, L. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000123 · Cited by 33
Self-citationTime‐to‐reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
Haisma, S., Verkade, H. J., Scheenstra, R., van der Doef, H. P. J., Bodewes, F. A. J. A., & van Rheenen, P. F. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002458 · Cited by 32
A Single‐center Experience With Methotrexate After Thiopurine Therapy in Pediatric Crohn Disease
Boyle, B., Mackner, L. M., Ross, C. S., Moses, J., Kumar, S., & Crandall, W. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181dd861a · Cited by 30
Foster, A., Smyth, M. D., Lakhani, A., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i10.1266 · Cited by 30
Ziv‐Baran, T., Hussey, S., Sładek, M., Dias, J. A., de Carpi, J. M., Miele, E., Veres, G., Lionetti, P., Koletzko, S., Nuti, F., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15016 · Cited by 29
Self-citationvan Rheenen, H., & van Rheenen, P. F. (2020) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2020.23.2.121 · Cited by 29
Hyams, J. S., Dubinsky, M. C., Rosh, J. R., Ruemmele, F. M., Eichner, S. F., Maa, J., Lazar, A., Alperovich, G., Mostafa, N. M., & Robinson, A. M. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15054 · Cited by 28
Self-citationLevine, A., Chanchlani, N., Hussey, S., Ziv‐Baran, T., Escher, J. C., Dias, J. A., Veres, G., Koletzko, S., Turner, D., Kolho, K.-L., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz111 · Cited by 28
Self-citationFranca, R., Curci, D., Lucafò, M., Decorti, G., & Stocco, G. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1630378 · Cited by 28
Probiotics for the maintenance of remission in Crohn's disease
Rolfe, V. E., Bath-Hextall, F. J., Fortun, P., & Hawkey, C. J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004826 · Cited by 27
Haisma, S. M., Lijftogt, T., Kindermann, A., Damen, G. M., de Ridder, L., Escher, J. C., Mearin, M. L., de Meij, T. G. J., Hendriks, D. M., George, E., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv031 · Cited by 26
Self-citationHukkinen, M., Pakarinen, M. P., Merras‐Salmio, L., Koivusalo, A., Rintala, R. J., & Kolho, K. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.01.017 · Cited by 26
Self-citation
Cited by
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Gordon, H., Minozzi, S., Kopylov, U., Verstockt, B., Chaparro, M., Buskens, C., Warusavitarne, J., Agrawal, M., Allocca, M., Atreya, R., et al. (2024) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjae091 · Cited by 388
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Bager, P., Escher, J., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Klek, S., Krznaric, Z., Ockenga, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.12.004 · Cited by 367
Self-citationValdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.016 · Cited by 89
Self-citationGatti, S., Gelzoni, G., Catassi, G. N., & Catassi, C. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.742830 · Cited by 14
Giachero, F., Jenke, A., & Zilbauer, M. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1945442 · Cited by 7
“we recommend reading the most recent ECCO-ESPGHAN guideline update [50].”
BackgroundMethodInfluential
Metadata
- Authors
- van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., Koletzko, S., Kolho, K.-L., Levine, A., van Limbergen, J., Martin de Carpi, F. J., Navas-López, V. M., Oliva, S., de Ridder, L., Russell, R. K., Shouval, D., Spinelli, A., Turner, D., Wilson, D., Wine, E., & Ruemmele, F. M.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-07
- Volume
- 15
- Issue
- 2
- Pages
- 171-194
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W3092023159
- Cited by
- 729
- References
- 213
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.